Comparing numbing medicines on the face
Part of Pain, Skin clinical trials.
This study tests how long different numbing medicines work on the face and forearm. It compares two medicines on different sides of the nose to see which lasts longer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have normal feeling in the skin of your nose and forearms
- You have never had a bad reaction to numbing medicine
- You are not pregnant or breastfeeding
- You are not taking certain depression medicines (MAOIs or tricyclic antidepressants)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two different numbing medicines on the sides of the nose to see how long each lasts and which works better.
This study compares two ways of numbing the skin during Mohs surgery for skin cancer on the face or scalp. It aims to find which method causes less pain and is more satisfying for patients.
This trial tests a topical anesthetic marker that numbs the skin before minor procedures. It's designed for healthy adults who need a quick and effective numbing option.
This study tests two different numbing medicines in people with high blood pressure who need a single upper tooth pulled. The goal is to see which one works better and keeps heart activity stable during the procedure.
This trial tests if two different medicines, dexamethasone and dexmedetomidine, given as a nerve block in your nose during rhinoplasty can better control pain after surgery.
This study tests two ways to stimulate a nerve in your face (trigeminal nerve) using a mild electrical current: one through the skin and one through the skull. The goal is to see what happens in the brain using MRI scans. It only includes healthy volunteers with no major health issues.
Hear when a new This Study Will Focus on In-office Dermatological Procedures trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.